Monte Rosa Therapeutics Inc
Biotechnology
Healthcare
GLUE
82.96 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
6.46
52 week high
10.36
high
6.55
52 week low
0.00
low
6.25
growth
-2.31 %
previous Close
6.53
P/E ratio
market cap
260 M
div yield
0
usd
Jun 2025
qoq
revenue
0.00 %
net incoming
0.00 %
eps
0.00 %
-162.46 %
eps surprise
6.32 %
net profit margin
0.00 %
-55.00 %
operating incoming
0.00 %
net change in cash
0.00 %
cash on hand
0.00 %
cost of revenue
0.00 %
top top